Opioid Lawsuit Settlement
Walmart Settles U.S. Government Opioid Lawsuit With Terms Remaining Undisclosed
Anonymous
Key Points
1
In March 2024, U.S. District Judge Colm Connolly narrowed the Walmart opioid case, dismissing claims that Walmart failed to report suspicious prescriptions to the DEA and other pharmacist-related conduct, thereby narrowing the federal litigation.
2
Walmart had separately sued the U.S. Department of Justice and the Drug Enforcement Administration in October 2020, arguing regulators imposed burdens on dispensing; that suit was dismissed in 2021.
3
A joint stipulation of dismissal was filed in the federal court in Wilmington, Delaware, formally ending the federal action.
4
The Department of Justice said it was pleased to have reached a settlement resolving allegations that Walmart's pharmacies failed to comply with the Controlled Substances Act in dispensing opioids and other controlled substances; the CDC also notes that overdose deaths rose through 2023 but began declining after 2022.
5
Walmart shares rose about 1% in trading after the settlement was announced, reflecting a market reaction to the resolution of the litigation.
Walmart has settled a federal government lawsuit over its role in the opioid epidemic, according to Justice Department confirmation, but the financial terms remain secret. The case, filed in 2020, accused the retailer's pharmacies of repeatedly violating the Controlled Substances Act by unlawfully dispensing opioids and other controlled drugs since 2013. A joint dismissal was filed in federal court in Wilmington, Delaware, ending the litigation.
The settlement comes after more than 905,000 Americans died from opioid overdoses between 1999 and 2025, according to health officials. Yahoo Finance reported Walmart's stock rose about 1% after the deal was announced. In 2022, Walmart agreed to pay $3.1 billion to settle similar claims from state and local governments.
A Federal Case Narrowed Before Settlement
In March 2024, U.S. District Judge Colm Connolly dismissed key parts of the lawsuit, removing claims that Walmart failed to report suspicious prescriptions to the DEA. That ruling significantly narrowed what remained of the federal case against the retail giant.
Walmart's Earlier Fight Against Federal Regulators
Walmart had previously challenged the government in its own lawsuit filed in October 2020. The retailer argued that federal regulators imposed unfair burdens on its pharmacy operations. That suit was dismissed in 2021, leaving the door open for the government's case to proceed.
Mystery Settlement Resolves Major Legal Overhang
The Justice Department said it was pleased to reach a settlement resolving allegations that Walmart's pharmacies failed to comply with federal law in dispensing opioids. Yahoo Finance noted that neither Walmart nor the government disclosed the financial cost. Legal observers say ending this case removes significant uncertainty for Walmart's business.
Broader Opioid Reckoning Continues Across Industry
Walmart's settlement is part of a larger government crackdown on companies fueling the opioid crisis. Purdue Pharma and drug distributor Cencora faced separate major actions. The CDC notes that overdose deaths rose through 2023 but began declining after 2022, offering a glimmer of hope amid the ongoing public health emergency.
Sentiment
Mostly NegativeNEGATIVENEUTRALPOSITIVE
Publishers
13
Articles
239
Reach
252
A
AnonymousAuthor
